2022
DOI: 10.1016/j.intimp.2021.108380
|View full text |Cite
|
Sign up to set email alerts
|

Taraxasterol mitigates Con A-induced hepatitis in mice by suppressing interleukin-2 expression and its signaling in T lymphocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 45 publications
0
2
0
Order By: Relevance
“…Con A was injected into mice to build hepatitis animal model, [ 38 , 39 ] and the experimental procedure was illustrated in Figure 6C . The injected Con A could accumulate in liver to activate the immune system and induce T‐cell‐dependent liver damage.…”
Section: Resultsmentioning
confidence: 99%
“…Con A was injected into mice to build hepatitis animal model, [ 38 , 39 ] and the experimental procedure was illustrated in Figure 6C . The injected Con A could accumulate in liver to activate the immune system and induce T‐cell‐dependent liver damage.…”
Section: Resultsmentioning
confidence: 99%
“…Among the T cells, we can see that CD8 + effector T cells were most obviously different between young and aged liver. To further study the alteration of inflammation level, especially CD8 + T cell infiltration, in the aged liver with injury, we established a classical autoimmune hepatitis model [ 35 , 36 , 37 ] by using 15 mg kg −1 concanavalin A (conA) in young and aged mice, in which CD8 + T cells were reported to play main roles at the stage of hepatocyte apoptosis and liver injury. [ 38 ] Eight hours after conA injection, we quantified total T‐cells by detecting CD3‐positive cells using flow cytometry and immunohistochemistry.…”
Section: Resultsmentioning
confidence: 99%
“…Our study extends these findings by demonstrating TAX's impact on BCa cell apoptosis. Interestingly, TAX exhibited anti-tumor efficacy in a mouse model of hepatocellular carcinoma, involving T lymphocytes [18], prompting further exploration of its effects on the BCa microenvironment. Additionally, TAX has shown promise in attenuating melanoma progression by targeting the ROS-mediated PI3K/Akt pathway [19].…”
Section: Discussionmentioning
confidence: 99%